- This event has passed.
Join the BioLaw and Health Policy Society and law firm Covington & Burling for a panel discussion on legal practice involving life sciences and health care. Corporate, transactional, regulatory, and litigation practice will all be represented! Lunch will be provided, courtesy of Covington & Burling.
RSVP here so we can order enough food!
Four partners from the San Francisco and Silicon Valley offices will discuss their practice areas and their recent interesting cases and transactions, and will take student questions. This is a great opportunity to learn about legal practice at a big law firm, both in these sectors and in general.
Panelists include:
1. Ingrid Rechtin, San Francisco Partner (corporate)
Ingrid Rechtin provides strategic legal advice to companies in the life sciences, technology, clean tech and fintech sectors, ranging from start-ups to global corporations. Her experience includes financings, corporate venture capital investments, mergers and acquisitions, licensing, joint ventures and general corporate matters.
2. Amy Toro, San Francisco Partner (transactional)
Amy Toro specializes in technology transactions, with particular emphasis on life science arrangements, such as collaboration and license agreements. Her clients include pharmaceutical companies, biotechnology clients, and non-profit organizations.
3. Scott Cunningham, San Francisco Partner (regulatory and public policy)
Scott Cunningham is a member of the firm’s Food and Drug practice group. He represents pharmaceutical, biotechnology, and medical device companies as well as trade associations in matters before the FDA, Congress, state and federal courts, and other regulatory and enforcement agencies.
4. Kurt Calia, Silicon Valley Partner (litigation)
Kurt Calia is a partner in the Silicon Valley office practicing in the areas of complex civil litigation, patent litigation, intellectual property, life sciences, and patent prosecution. His practice focuses largely on the firm’s high technology clients in a wide range of areas including pharmaceutical chemistry, agricultural biotechnology, biomedical devices, nanotechnology, genetics, mechanical devices, business methods, microprocessors, and software.